Hale Akpınar

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Clinical Characteristics of Inflammatory Bowel Disease in Turkey

Nurdan Tözün, Özlen Atuğ, Neşe İmeryüz et al. · Journal of Clinical Gastroenterology · 2008 · 75 citations

Medicine, Clinical Sciences, Internal Medicine +9

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 70 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6

Comparison of High Resolution Magnifying Endoscopy and Standard Videoendoscopy for the Diagnosis of <i>Helicobacter pylori</i> Gastritis in Routine Clinical Practice: A Prospective Study

Can Gönen, İlkay Şımşek, Sülen Sarıoğlu et al. · Helicobacter · 2009 · 65 citations · Full text

Medicine, Clinical Sciences, Pathology +12

Irritable Bowel Syndrome in Persons Who Acquired Trichinellosis

Müjde Soytürk, Hale Akpınar, Oğuz Gürler et al. · The American Journal of Gastroenterology · 2007 · 55 citations

Medicine, Infectious Diseases, Microbiology +15